Peer-reviewed veterinary case report
Endocannabinoid oxygenation by prostaglandin H synthase-2: Chemistry and biology.
- Year:
- 2025
- Authors:
- Rouzer CA & Marnett LJ.
- Affiliation:
- Vanderbilt Institute of Chemical Biology · United States
Abstract
Prostaglandin (PG) endoperoxide synthases (PGHS)-1 and -2 oxygenate arachidonic acid to PGH<sub>2</sub>, the precursor to PGs and thromboxane. PGHS-2 also oxygenates ester and amide substrates more efficiently than PGHS-1. Foremost among these neutral substrates are the endocannabinoids, arachidonoylethanolamide and 2-arachidonoylglycerol (2-AG). 2-AG is the most abundant endocannabinoid and a full agonist for both cannabinoid receptors, CB1 and CB2. PGHS-2-mediated oxygenation of 2-AG ultimately produces PG glycerol esters, which exhibit biological activities largely independent of classical endocannabinoid and PG receptors. This article reviews the mechanism of PGHS-2 oxygenation of 2-AG, the kinetic and structural basis for its biochemical regulation, the occurrence of 2-AG oxygenation in cells and in vivo, and the biological impact of the pathway. Gaps in our knowledge and challenges to a fuller understanding of the impact of PGHS-2 oxygenation of 2-AG are presented.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://europepmc.org/article/MED/41167310